Contributed Papers
Empowering Clinical Trials through Innovative Bayesian Design and Analysis
Philip HeChair
Biopharmaceutical Section
7 Presentations
2:05 PM - 2:20 PM
Bayesian MultiState Mediation Model Elucidates the Impact of Treatment Response on Oncology Endpoint
2:20 PM - 2:35 PM
Co-authors: Yiqing Chen, Jie Zhou (Neuroscience Biostatistics, Novartis Pharmaceutical Cooperation, East Hanover, New Jersey, USA), Yiqing Chen, Peng Wei (University of Texas, MD Anderson Cancer Center), Qing Liu (Amgen), Xun Jiang (Amgen), Amy Xia (Amgen), Steven Lin (Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, U), Radhe Mohan (Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, U), Brian Hobbs (University of Texas)
2:35 PM - 2:50 PM
Co-authors: Akiyoshi Nakakura (Center for Clinical and Translational Research, Kyushu University Hospital), Akiyoshi Nakakura (Center for Clinical and Translational Research, Kyushu University Hospital)
2:50 PM - 3:05 PM
Co-authors: Bhramori Banerjee (Merck & Co., Inc.), Bhramori Banerjee (Merck & Co., Inc.), Jia Hua (Merck), Jun Lu (University of Illinois Chicago)
3:05 PM - 3:20 PM
Co-authors: Zejiang Yang (Syneos Health), Zejiang Yang (Syneos Health), Xiaoqiang Xue (Syneos Health)
3:20 PM - 3:35 PM
Co-authors: Ke Zhu (NCSU and Duke), Shu Yang (North Carolina State University, Department of Statistics), Ke Zhu (NCSU and Duke), Xiaofei Wang (Duke University Medical Center)
3:35 PM - 3:50 PM
Co-authors: Vahan Aslanyan (University of Southern California), Michelle Nuño (University of Southern California), Vahan Aslanyan (University of Southern California), Trevor A. Pickering (University of Southern California), Lindsay A. Renfro (University of Southern California), Judy Pa (University of California, San Diego), Wendy Mack (University of Southern California)